#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Kenneth Hess Email
Director, Business Development and Commercial . Volastra Therapeutics
New York, NY
LocationPrimary Email
How to contact Kenneth Hess
Join and see Kenneth's contact info for free!Current Roles
Employees:
55Revenue:
$4.3MAbout
Volastra Therapeutics, Inc., is developing novel therapies to treat and prevent the formation of metastatic disease. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and proliferation of metastases. Following initial evidence that a patient's CIN status is prognostic for metastasis and that CIN alters metastasis and overall survival in mouse models, the company is discovering mechanisms and pathways by which CIN modulates metastatic disease to develop novel therapeutics.Volastra Therapeutics Address
1361 Amsterdam AveNew York, NY
United States